<?xml version="1.0" encoding="UTF-8"?>
<ref id="B62-pharmaceuticals-13-00313">
 <label>62.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dao</surname>
    <given-names>T.T.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>P.H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>S.I.</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>W.K.</given-names>
   </name>
  </person-group>
  <article-title>Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from 
   <italic>Glycyrrhiza inflate</italic>
  </article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2011</year>
  <volume>21</volume>
  <fpage>294</fpage>
  <lpage>298</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.11.016</pub-id>
  <pub-id pub-id-type="pmid">21123068</pub-id>
 </element-citation>
</ref>
